10-Q Filing

NEXSCIENT, INC. CIK: 1976663 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001477932-23-009342`
Period End Date	20230930
Filing Date	20231227
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	nexscient_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 7 Cash Flow Statement 16 Stockholders Equity 7

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$202.46K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$436.13K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$202.46K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$436.13K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$436.13K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$202.46K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.96M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.53M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.85K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartyCurrent`	$28.86K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartyCurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.96M	shares	Point-in-time
Advances from related party	`AdvancesFromRelatedPartyCurrent`	$500.00	USD	Point-in-time
Advances from related party	`AdvancesFromRelatedPartyCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$29.36K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$8.85K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$29.36K	USD	Point-in-time
Preferred Stock 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding at September 30 and June 30, 2023, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding at September 30 and June 30, 2023, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock 75,000,000 shares authorized, $0.001 par value, 19,955,980 and 16,528,000 shares issued and outstanding at September 30, and June 30, 2023, respectively	`CommonStockValue`	$19.96K	USD	Point-in-time
Common stock 75,000,000 shares authorized, $0.001 par value, 19,955,980 and 16,528,000 shares issued and outstanding at September 30, and June 30, 2023, respectively	`CommonStockValue`	$16.53K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$404.84K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$744.21K	USD	Point-in-time
Subscriptions receivable	`SubscriptionsReceivable`	-	USD	Point-in-time
Subscriptions receivable	`SubscriptionsReceivable`	$-154.50K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-93.77K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-336.88K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquity`	$173.10K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquity`	$427.28K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$202.46K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$436.13K	USD	Point-in-time

Income Statement 7 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$15.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$228.12K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$243.12K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-243.12K	USD	1 Quarter
BASIC AND DILUTED LOSS PER COMMON SHARE	`EarningPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	19.53M	shares	1 Quarter

Cash Flow Statement 16 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-243.12K	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$150.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$8.85K	USD	1 Quarter
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-28.86K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-113.13K	USD	1 Quarter
Repayment of advance from related party	`RepaymentsOfRelatedPartyDebt`	$500.00	USD	1 Quarter
Proceeds from shares issued for cash	`ProceedsFromSharesIssuedForCash`	$192.80K	USD	1 Quarter
Proceeds from subscriptions receivable	`ProceedsFromCollectionOfOtherReceivables`	$154.50K	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$346.80K	USD	1 Quarter
NET INCREASE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$233.67K	USD	1 Quarter
CASH AT BEGINNING OF THE PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$436.13K	USD	Point-in-time
CASH AT BEGINNING OF THE PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$202.46K	USD	Point-in-time
CASH AT END OF THE PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$436.13K	USD	Point-in-time
CASH AT END OF THE PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$202.46K	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter

Stockholders Equity 7 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquity`	$173.10K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$427.28K	USD	Point-in-time
Stock issued for services, amount	`StockIssuedDuringPeriodValueIssuedForServices`	$150.00K	USD	1 Quarter
Stock issued for cash, amount	`StockIssuedForCashAmount`	$347.30K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-243.12K	USD	1 Quarter
Balance, amount	`StockholdersEquity`	$173.10K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$427.28K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.